Proof-of-concept Study on Dyspnea Analysis Via GapCO2
Condition(s) studied
Study summary
Patients presenting to the emergency department with acute dyspnea undergo arterial blood gas measurement and monitoring of transcutaneous capnography using the TCM5 monitor. The aim of this study is to determine whether GapCO2, the difference between transcutaneous and arterial pCO2 (PaCO2 - PtcCO2), is correlated with the congestive or non-congestive origin of dyspnea.
Eligibility
Primary outcome measure(s)
- GapCO2 — Within 1 hour after enrolment
PaCO2 measured via arterial blood gas analysis - PtcCO2 measured via TCM5 monitor, at 37°C
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Emergency Department Hospital Avicenne | Bobigny | France | Recruiting |
More Assistance Publique - Hôpitaux de Paris trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06556797 on ClinicalTrials.gov ↗ ← All trials in France